Skip to Content

8 Results Found

  • Feature Paper
  • Review
  • Open Access
39 Citations
7,512 Views
27 Pages

Rho Family GTPases and Rho GEFs in Glucose Homeostasis

  • Polly A. Machin,
  • Elpida Tsonou,
  • David C. Hornigold and
  • Heidi C. E. Welch

16 April 2021

Dysregulation of glucose homeostasis leading to metabolic syndrome and type 2 diabetes is the cause of an increasing world health crisis. New intriguing roles have emerged for Rho family GTPases and their Rho guanine nucleotide exchange factor (GEF)...

(This article belongs to the Special Issue Regulation and Function of Small GTPases 2.0)
  • Review
  • Open Access
11 Citations
6,277 Views
17 Pages

9 June 2020

Since their discovery, Rho GTPases have emerged as key regulators of cytoskeletal dynamics. In humans, there are 20 Rho GTPases and more than 150 regulators that belong to the RhoGEF, RhoGAP, and RhoGDI families. Throughout development, Rho GTPases c...

(This article belongs to the Special Issue Rho family of GTPases in Model Organisms and Systems)
  • Article
  • Open Access
1 Citations
1,947 Views
15 Pages

5 September 2025

It has previously been reported that the RhoA/Rho-associated kinase (ROCK) pathway is involved in depolarization-induced contraction triggered by high [K+] stimulation in rat caudal arterial smooth muscle. Furthermore, we reported that activation of...

(This article belongs to the Special Issue Smooth Muscle Cells in Vascular Disease)
  • Review
  • Open Access
29 Citations
6,935 Views
17 Pages

Role of Small GTPase RhoA in DNA Damage Response

  • Chibin Cheng,
  • Daniel Seen,
  • Chunwen Zheng,
  • Ruijie Zeng and
  • Enmin Li

3 February 2021

Accumulating evidence has suggested a role of the small GTPase Ras homolog gene family member A (RhoA) in DNA damage response (DDR) in addition to its traditional function of regulating cell morphology. In DDR, 2 key components of DNA repair, ataxia...

(This article belongs to the Special Issue Genome Maintenance Systems: Small Molecule Modulators, Mechanisms, Regulation and Clinical Implications)
  • Article
  • Open Access
17 Citations
4,392 Views
16 Pages

RhoGDI2-Mediated Rac1 Recruitment to Filamin A Enhances Rac1 Activity and Promotes Invasive Abilities of Gastric Cancer Cells

  • Hyo-Jin Kim,
  • Ki-Jun Ryu,
  • Minju Kim,
  • Taeyoung Kim and ,
  • Seon-Hee Kim,
  • Hyeontak Han,
  • Hyemin Kim,
  • Keun-Seok Hong,
  • Chae Yeong Song and
  • Jiyun Yoo
  • + 8 authors+ 3 authors

5 January 2022

Rho GDP dissociation inhibitor 2 (RhoGDI2), a regulator of Rho family GTPase, has been known to promote tumor growth and malignant progression in gastric cancer. We previously showed that RhoGDI2 positively regulates Rac1 activity and Rac1 activation...

(This article belongs to the Special Issue Understanding Molecular Regulation of Cancer Progression and Metastasis)
  • Review
  • Open Access
34 Citations
8,656 Views
24 Pages

Emerging Roles of Small GTPases in Islet β-Cell Function

  • Rajakrishnan Veluthakal and
  • Debbie C. Thurmond

15 June 2021

Several small guanosine triphosphatases (GTPases) from the Ras protein superfamily regulate glucose-stimulated insulin secretion in the pancreatic islet β-cell. The Rho family GTPases Cdc42 and Rac1 are primarily involved in relaying key signals in s...

(This article belongs to the Special Issue Rho family of GTPases in Model Organisms and Systems)
  • Article
  • Open Access
94 Citations
8,390 Views
18 Pages

Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Actin Dynamics

  • Tali Voloshin,
  • Rosa Sara Schneiderman,
  • Alexandra Volodin,
  • Reuben Ruby Shamir and ,
  • Noa Kaynan,
  • Einav Zeevi,
  • Lilach Koren,
  • Anat Klein-Goldberg,
  • Rom Paz and
  • Yoram Palti
  • + 8 authors+ 3 authors

17 October 2020

Tumor Treating Fields (TTFields) are noninvasive, alternating electric fields within the intermediate frequency range (100–300 kHz) that are utilized as an antimitotic cancer treatment. TTFields are loco-regionally delivered to the tumor region...

(This article belongs to the Special Issue Targeted Therapies for the Treatment of Glioblastoma)
  • Article
  • Open Access
809 Views
19 Pages

YAP1 Upregulates Cytoskeleton Regulator ARHGEF1 and Tissue Regeneration Factor NEDD9 in a Multiplex Proteomic Study

  • Dinesh Devadoss,
  • Juliet Akkaoui,
  • Arti Vashist,
  • Adriana Yndart Arias and ,
  • Adel Nefzi and
  • Madepalli K. Lakshmana
  • + 1 author+ 0 author

Background/Objectives: Yes-associated protein 1 (YAP1) is a transcriptional cofactor that coordinates the complex interplay between cell proliferation, survival, differentiation, metabolism, biomechanics, and tissue regeneration. Previous studies hav...

(This article belongs to the Special Issue Molecular Research of CNS Diseases and Neurological Disorders)